EYLEA HD

aflibercept · Regeneron Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for EYLEA HD, covering 2023-08-18 to 2026-04-02. Get the full timeline:

Most recent: FDA Approved: EYLEA HD — Supplemental Application (Regeneron Pharmaceuticals, Inc)